Delivery Order SPE2DB22D2206-SPE2DB25FJT07
- Not listed
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Columvi 10 mg/10 mL vials. This competitively awarded, firm fixed-price delivery order has a ceiling value of $21,382.17 and is scheduled for completion by September 9, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was used in this award. This delivery...
- The Defense Logistics Agency Medical Supply Chain awarded a $21,382.17 delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for Columvi 10 mg/10 mL vials. This is a firm fixed-price, competitively awarded contract with performance to be completed by August 27, 2025, at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under a larger indefinite delivery contract vehicle. This delivery order is issued under...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $21,197.66 to AmerisourceBergen Drug Corp on August 9, 2025, with completion scheduled for August 11, 2025. This firm fixed-price, non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The delivery order will be performed at the contractor's corporate...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $152,556.74 to AmerisourceBergen Drug Corp on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed price, competitively awarded delivery order (Contract No. 4569202619) represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical. The order is to be performed at AmerisourceBergen's corporate...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $40,205.76 to AmerisourceBergen Drug Corp on September 15, 2025, with an ultimate completion date of September 16, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supply fulfillment. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The U.S. Defense Logistics Agency's Medical Supply Chain issued a delivery order valued at $40,959.52 to AmerisourceBergen Drug Corp on September 8, 2025, with an ultimate completion date of September 9, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. AmerisourceBergen Drug...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order contract valued at $45,231.48 to AmerisourceBergen Drug Corp on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The order will be fulfilled from the vendor's Corporate Office location in Conshohocken, Pennsylvania....
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $23,237.52 to AmerisourceBergen Drug Corp on August 21, 2025, with an ultimate completion date of August 22, 2025. This firm fixed-price delivery order, issued under a competitively awarded contract with no set-aside designation, will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $16,742.76 to AmerisourceBergen Drug Corp on September 5, 2025, with an ultimate completion date of September 8, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supply fulfillment. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform work at its corporate...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $34,535.20 to AmerisourceBergen Drug Corp on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed-price, non-set-aside contract is a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJT07Delivery Order
The Defense Logistics Agency awarded a $21,382.17 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Columvi 10 mg/10 mL vials. The contract, which represents no set-aside designation, has an ultimate completion date of September 24, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. This competitively awarded delivery order demonstrates the company's ongoing capability to supply specialized pharmaceutical products to support Defense Health Agency and other federal healthcare programs. As a child contract under the DLA's comprehensive pharmaceutical supply vehicle, this award reflects AmerisourceBergen's participation in the Defense Logistics Agency's medical supply chain network, which provides pharmaceutical products and medical supplies across multiple therapeutic domains to military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.4k | 9/3/25 |